It makes no sense to uplist right now (if ever this is allowed) just to risk delisting if PPS goes below $1.
Uplisting still pending, it will happen short term now that governance issues are cleared. A wonderful entry point today to play this catalyst IMO.
Sentiment: Strong Buy
Jason Napodano: "NVIV now saying the 5-person pilot study will NOT be sufficient to gain approval under HUD. Larger, controlled, pivotal study will follow."
From today PR: "Consistent with FDA guidance, the Company then expects to conduct a pivotal study with a control group to obtain FDA approval to commence commercialization under a Humanitarian Device Exemption."
This is no good news indeed.
Do you prefer to sell more of your shares when the price is low or when it's higher? Reynolds is preparing to make more money with the impending PPS appreciation in the second half of the year IMO.
I think that no informed investor expects the trial to start "on or before July 4th". Mr Reynolds' exact words at the annual shareholder CC were: "So, we expect to start our first patients this summer. So, if we start, let’s say, around July 4th, so that by the end of August we surely have something to report to people. So, we are really getting excited about kicking off the summer."
I completely agree with you, fagenbecker. At $80 I could easily retire, albeit at that point a simple double of the PPS could make me retire as a rich man.
Thanks for your analysis, pefact. When you derive a $50-90 PPS from a market capitalization of $50-90 billion are you factoring in a huge future dilution? With the current 90M of outstanding shares (fully diluted) and a $50-90B market cap, NVIV would have a PPS of $555-1000, if I am not mistaken.
Don't you think they will uplist before trial start? That event alone could foster some significant buy pressure IMO. My guess is uplisting to happen before end of Summer, possibly much earlier.
I think that has no relevance whatsoever to NVIV. Apparently someone here think that NVIV PPS is being 'manipulated'. Complete BS if you ask me...